Bioline RX Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bioline RX Ltd - ADR
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
/ 
Frequently asked questions
To buy Bioline RX Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bioline RX Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bioline RX Ltd - ADR is BLRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bioline RX Ltd - ADR has its primary listing on NASDAQ (Small cap). You can trade Bioline RX Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bioline RX Ltd - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Bioline RX Ltd - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like Bioline RX Ltd - ADR or others.